MediWound (MDWD) Interest Coverage Ratio (2013 - 2026)
MediWound (MDWD) posted Interest Coverage Ratio of 8.44 for Q2 2026, up 166.63% on a QoQ basis from 3.16 in Q4 2025, and up 1079.81% year-over-year from 0.72 in Q2 2025.
Powered by 
Analysis
MediWound (MDWD) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
MediWound has reported Interest Coverage Ratio for 14 years, with the latest figure at 8.44 in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio rose 1079.81% year-over-year to 8.44 in Q2 2026; TTM through Jun 2026 was 4.18, a 113.51% increase from a year earlier, with the FY2025 full-year figure at 10.27, up 577.96% from the prior year.
- Interest Coverage Ratio was 8.44 for Q2 2026 at MediWound, up from 3.16 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 8.44 in Q2 2026, with the low at 1306.25 in Q1 2025.
- Average Interest Coverage Ratio over 5 years is 115.11, with a median of 4.49 recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio slumped 61.64% in 2025, then jumped 1079.81% in 2026.
- Over 5 years, Interest Coverage Ratio stood at 5.66 in 2022, then dropped by 20.74% to 4.49 in 2023, then sank by 58.45% to 1.86 in 2024, then jumped by 69.72% to 3.16 in 2025, then soared by 166.63% to 8.44 in 2026.
- The last three Interest Coverage Ratio figures came in at 8.44 (Q2 2026), 3.16 (Q4 2025), and 1.64 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 | -8.44 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.44 |
| Dec 31, 2025 | 3.16 |
| Sep 30, 2025 | -1.64 |
| Jun 30, 2025 | 0.72 |
| Mar 31, 2025 | -1,306.25 |
| Jun 30, 2024 | 1.86 |
| Jun 30, 2023 | 4.49 |
| Dec 31, 2022 | 5.66 |
| Sep 30, 2022 | 4.49 |
| Jun 30, 2022 | 5.35 |
| Mar 31, 2022 | 7.46 |
| Dec 31, 2021 | 5.54 |
| Sep 30, 2021 | 6.31 |
| Jun 30, 2021 | 7.26 |
| Mar 31, 2021 | 2.04 |
| Dec 31, 2020 | -3.63 |
| Sep 30, 2020 | 2.85 |
| Jun 30, 2020 | 5.51 |
| Mar 31, 2020 | 4.47 |
| Dec 31, 2019 | 8.23 |